AT Bancorp cut its stake in shares of IMS Health Holdings Inc. (NYSE:IMS) by 37.4% during the third quarter, Holdings Channel reports. The fund owned 40,849 shares of the company’s stock after selling 24,430 shares during the period. AT Bancorp’s holdings in IMS Health Holdings were worth $1,280,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Acrospire Investment Management LLC increased its position in IMS Health Holdings by 31.3% in the second quarter. Acrospire Investment Management LLC now owns 4,200 shares of the company’s stock valued at $107,000 after buying an additional 1,000 shares during the last quarter. Nordea Investment Management AB increased its position in IMS Health Holdings by 9.3% in the second quarter. Nordea Investment Management AB now owns 4,811 shares of the company’s stock valued at $122,000 after buying an additional 411 shares during the last quarter. LS Investment Advisors LLC increased its position in IMS Health Holdings by 14.0% in the second quarter. LS Investment Advisors LLC now owns 4,982 shares of the company’s stock valued at $126,000 after buying an additional 611 shares during the last quarter. BNP Paribas Arbitrage SA increased its position in IMS Health Holdings by 83.8% in the second quarter. BNP Paribas Arbitrage SA now owns 4,993 shares of the company’s stock valued at $127,000 after buying an additional 2,276 shares during the last quarter. Finally, Seven Eight Capital LLC purchased a new position in IMS Health Holdings during the first quarter valued at $191,000. 90.25% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for IMS Health Holdings (NYSE:IMS)

Shares of IMS Health Holdings Inc. (NYSE:IMS) remained flat at $31.34 during midday trading on Tuesday. IMS Health Holdings Inc. has a 52 week low of $22.36 and a 52 week high of $31.34. The firm has a 50-day moving average price of $31.34 and a 200 day moving average price of $28.83.

TRADEMARK VIOLATION WARNING: “IMS Health Holdings Inc. (IMS) Position Decreased by AT Bancorp” was first reported by Financial Market News and is the propert of of Financial Market News. If you are viewing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this piece can be read at http://www.financial-market-news.com/ims-health-holdings-inc-ims-position-decreased-by-at-bancorp/1209503/.

Several research firms recently weighed in on IMS. Zacks Investment Research downgraded IMS Health Holdings from a “buy” rating to a “hold” rating in a research note on Saturday, August 6th. TheStreet downgraded IMS Health Holdings from a “buy” rating to a “hold” rating in a research note on Monday, August 29th. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $30.71.

About IMS Health Holdings

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

5 Day Chart for NYSE:IMS

Want to see what other hedge funds are holding IMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMS Health Holdings Inc. (NYSE:IMS).

Receive News & Ratings for IMS Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.